Delivery Order SPE2DB22D3301-SPE2DB25FY8LP
- Not listed
- The Defense Logistics Agency awarded a $3,172.86 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child delivery order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, valued at $1,403.88. This firm fixed price delivery order, which is not set-aside and was competitively awarded, is set for ultimate completion on July 29, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, with performance occurring at the...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a $4,531.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with an ultimate completion date of August 5, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units) with a ceiling value of $2,763.95 and an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order, indicating it falls under a larger indefinite delivery contract vehicle. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a $3,725.44 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase inhibitor commonly used in hormone therapy for breast cancer treatment, reflecting the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets (30-count) under a firm fixed-price contract valued at $6,868.86. The order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $6,117.34 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a quantity of 90s. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. The products will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Letrozole is an aromatase...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5mg (90-count supply) valued at $6,490.08 under a firm fixed price contract type. The award was made on July 24, 2025, with an ultimate completion date of the same day, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at $1,081.68, for the supply of Letrozole 2.5 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of August 6, 2025. The award was issued on August 5, 2025, with performance to be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Letrozole is a...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8LPDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This contract, valued at $1,802.80 with a firm fixed price structure, represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by July 29, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX and active through December 2026. The IDC serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in the Defense Logistics Agency's medical supply chain, consistently delivering diverse pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/28/25 |